OPTI — OptiBiotix Health Cashflow Statement
0.000.00%
Last trade - 00:00
- £17.63m
- £16.74m
- £0.46m
- 52
- 48
- 45
- 44
2018 November 30th | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 13 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -1.5 | -2.17 | -1.11 | -1.37 | -2.49 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 0.131 | 0.137 | 0.137 | 0.06 | 0.011 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.007 | 0.088 | -0.201 | -0.548 | 1.15 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -1.23 | -1.72 | -0.928 | -1.56 | -1.11 |
Capital Expenditures | -0.473 | -0.595 | -0.35 | -0.194 | -0.168 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.002 | — | — | — | -0.163 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale/Maturity of Investment | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.471 | -0.595 | -0.35 | -0.194 | -0.331 |
Financing Cash Flow Items | — | 0.617 | 0.747 | 2.9 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.78 | 1.45 | 1.69 | 2.9 | 0.485 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.077 | -0.869 | 0.409 | 1.14 | -0.955 |